291 healthtech investors in Europe
We list 291 healthtech investors in Europe as of November 2026: 1 has an SEC filing on file and 290 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The cities with the most head offices on this list are Paris (60), Stockholm (11) and Barcelona (9).
Top 10 healthtech investors in Europe, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Innovation Industries
Type: VC firm · HQ: Amsterdam, Netherlands · Stages: Series A, Series B, Growth · Focus: Healthtech, Deep Tech, AI, Food and Beverage · Latest activity: New fund, Oct 2026 · Fund size or assets: €1.0B (own site)
Latest fund filing dated Oct 2026; €1.0B on file (own site); states healthtech and digital health as a focus; 4 named decision-makers on file.
Cathay Innovation
Type: VC firm · HQ: Paris, France · Stages: Seed, Series A, Series B, Growth, Late stage · Focus: Healthtech, AI, Robotics, Fintech · Latest activity: Portfolio news, Aug 2026 · Fund size or assets: €2.5B (own site)
Portfolio news dated Aug 2026; €2.5B on file (own site); states healthtech and digital health as a focus; 5 named decision-makers on file.
HBM Partners
Type: Fund manager · HQ: Zug, Switzerland · Stages: Series A, Series B, Growth, Late stage · Focus: Healthtech, Biotech, Medtech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: $2.8B (own site)
Portfolio news dated Oct 2026; $2.8B on file (own site); states healthtech and digital health as a focus; 1 named decision-maker on file.
Andera Partners
Type: Fund manager · HQ: Paris, France · Stages: Seed, Series A, Series B, Growth · Focus: Healthtech, Biotech, Medtech, Generalist · Latest activity: Portfolio news, Sep 2026 · Fund size or assets: €6.0B (own site)
Portfolio news dated Sep 2026; €6.0B on file (own site); states healthtech and digital health as a focus.
OneTarget
Type: VC firm · HQ: Berlin, Germany · Stages: Seed, Series A, Series B, Growth · Focus: Healthtech, AI, Fintech, Consumer · Latest activity: Portfolio news, Sep 2026 · Fund size or assets: $3.0B (own site)
Portfolio news dated Sep 2026; $3.0B on file (own site); states healthtech and digital health as a focus.
P101
Type: VC firm · HQ: Milan, Italy · Stages: Seed, Series A, Growth · Focus: Healthtech, Generalist, SaaS, Fintech · Latest activity: New deal, Oct 2026 · Fund size or assets: €500M (own site)
Dated new deal in Oct 2026; €500M on file (own site); states healthtech and digital health as a focus; 4 named decision-makers on file.
Truffle Capital
Type: VC firm · HQ: Paris, France · Focus: Healthtech, Biotech, Medtech, Fintech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: €500M (own site)
Portfolio news dated Oct 2026; €500M on file (own site); states healthtech and digital health as a focus; 3 named decision-makers on file.
Fountain Healthcare Partners
Type: VC firm · HQ: Dublin, Ireland · Stages: Seed · Focus: Healthtech, Biotech, Medtech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: €425M (own site)
Portfolio news dated Oct 2026; €425M on file (own site); states healthtech and digital health as a focus; 2 named decision-makers on file.
Capricorn Partners
Type: VC firm · HQ: Leuven, Belgium · Stages: Seed, Series A, Series B, Growth · Focus: Healthtech, Deep Tech, Climate Tech, SaaS · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: €300M (own site)
Portfolio news dated Oct 2026; €300M on file (own site); states healthtech and digital health as a focus; 5 named decision-makers on file.
IBB Ventures
Type: Government or university fund · HQ: Berlin, Germany · Stages: Pre-seed, Seed, Series A · Focus: Healthtech, SaaS, Industrial Tech, Consumer · Latest activity: New deal, Oct 2026 · Fund size or assets: €300M (own site)
Dated new deal in Oct 2026; €300M on file (own site); states healthtech and digital health as a focus; 5 named decision-makers on file.
First 25 of 291 healthtech investors in Europe
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Innovation Industries | VC firm | Amsterdam, Netherlands | Series A, Series B, Growth | Healthtech, Deep Tech, AI, Food and Beverage | New fund, Oct 2026 | €1.0B (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Cathay Innovation | VC firm | Paris, France | Seed, Series A, Series B, Growth, Late stage | Healthtech, AI, Robotics, Fintech | Portfolio news, Aug 2026 | €2.5B (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | $2.8B (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Healthtech, Biotech, Medtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 7 Nov 2026 | No contact on file |
| OneTarget | VC firm | Berlin, Germany | Seed, Series A, Series B, Growth | Healthtech, AI, Fintech, Consumer | Portfolio news, Sep 2026 | $3.0B (own site) | 4 Nov 2026 | firm email · Unlock |
| P101 | VC firm | Milan, Italy | Seed, Series A, Growth | Healthtech, Generalist, SaaS, Fintech | New deal, Oct 2026 | €500M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Truffle Capital | VC firm | Paris, France | Healthtech, Biotech, Medtech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock | |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Healthtech, Biotech, Medtech | Portfolio news, Oct 2026 | €425M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| Capricorn Partners | VC firm | Leuven, Belgium | Seed, Series A, Series B, Growth | Healthtech, Deep Tech, Climate Tech, SaaS | Portfolio news, Oct 2026 | €300M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| IBB Ventures | Government or university fund | Berlin, Germany | Pre-seed, Seed, Series A | Healthtech, SaaS, Industrial Tech, Consumer | New deal, Oct 2026 | €300M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Healthtech, Medtech, Biotech | New fund, Sep 2026 | €300M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Kibo Ventures | VC firm | Spain | Seed, Series A, Series B | Healthtech, Generalist, SaaS, Cybersecurity | New fund, Oct 2026 | €500M (own site) | 7 Nov 2026 | 5 names · Unlock |
| Ventech | VC firm | Paris, France | Pre-seed, Seed, Series A | Healthtech, AI, SaaS, B2B | New deal, Oct 2026 | €175M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Rubio Impact Ventures | VC firm | Amsterdam, Netherlands | Seed, Series A | Healthtech, Impact, Climate Tech, Energy | New fund, Sep 2026 | €226M (own site) | 7 Nov 2026 | firm email · Unlock |
| Claris Ventures | VC firm | Turin, Italy | Pre-seed, Seed, Series A | Healthtech, Biotech | New fund, Oct 2026 | €190M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Brightlands Venture Partners (BVP) | VC firm | Geleen, Netherlands | Seed, Series A | Healthtech, Agritech, Food and Beverage, Climate Tech | Portfolio news, Sep 2026 | €120M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Healthtech, Biotech, Medtech | New deal, Sep 2026 | €230M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
| Ship2B Ventures | VC firm | Barcelona, Spain | Pre-seed, Seed, Series A | Healthtech, Climate Tech, Edtech | New deal, Sep 2026 | €160M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Angelor | VC firm | Lyon, France | Seed, Series A | Healthtech, Biotech, Medtech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name · Unlock |
| Graduate Ventures | VC firm | Netherlands | Pre-seed, Seed | Healthtech, Deep Tech, Climate Tech, AI | New fund, Oct 2026 | €125M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Healthtech, Medtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| GoHub Ventures | VC firm | Valencia, Spain | Seed, Series A | Healthtech, SaaS, AI, B2B | Portfolio news, Oct 2026 | €90M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| Biovance Capital | VC firm | Lisbon, Portugal | Seed, Series A | Healthtech, Biotech | New deal, Sep 2026 | €60M (own site) | 7 Nov 2026 | 4 names · Unlock |
| Coinvest Capital | Government or university fund | Lithuania | Pre-seed, Seed, Series A | Healthtech, Climate Tech, Deep Tech, AI | Portfolio news, Oct 2026 | €44M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| Lauxera Capital Partners | VC firm | Paris, France | Growth | Healthtech, Medtech | New fund, May 2026 | €800M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
You are seeing 25 of 291. The full list adds 266 more investors and 880 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 291 break down
By European country
| European country | On this list | Share |
|---|---|---|
| France | 84 | 29% |
| Netherlands | 30 | 10% |
| Germany | 28 | 10% |
| Spain | 25 | 9% |
| Sweden | 18 | 6% |
| Italy | 14 | 5% |
| Austria | 11 | 4% |
| Norway | 10 | 3% |
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 100 | 34% |
| Seed | 215 | 74% |
| Series A | 156 | 54% |
| Series B | 59 | 20% |
| Growth | 119 | 41% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 184 | 63% |
| Fund manager | 31 | 11% |
| Government or university fund | 27 | 9% |
| Corporate VC | 16 | 5% |
| Angel network | 16 | 5% |
| Accelerator | 8 | 3% |
Method and limits
- Source
- 1 of the 291 rows carries an SEC filing (Form D or Form ADV). All 291 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states healthtech and digital health as a focus on its own site, or we observed it in the firm's portfolio.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 291 rows: stage 268, sector 291, fund size 109, website 291. In the paid file: named decision-makers on 234 rows, firm email on 193, LinkedIn page on 212, check size on 106.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many healthtech investors in Europe are there?
We list 291 as of November 2026. 97 of the 291 have a fund filing or a dated deal in the last 12 months. The cities with the most are Paris (60), Stockholm (11) and Barcelona (9).
Which healthtech investors in Europe raised a new fund in the last 12 months?
4 of the 291 have a fund filing dated in the last 12 months. The most recent on this list are Claris Ventures (Oct 2026), Graduate Ventures (Oct 2026) and GO CAPITAL (Jun 2026).
What is the typical fund size of healthtech investors in Europe?
None of the 291 discloses a fund size on an SEC Form D, so there is no median to give. 109 rows carry a size or assets figure from another public source, for example Innovation Industries at €1.0B (own site) and Cathay Innovation at €2.5B (own site).
Which stage do most healthtech investors in Europe back?
Of the 268 with a stage on file, seed (215), Series A (156) and growth-stage (119). A firm can back more than one stage, and 23 rows have no stage on file yet.
Where does the data on healthtech investors in Europe come from and how often is it updated?
1 of the 291 rows has an SEC filing on file (Form D or Form ADV) and 290 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Can I download the list of healthtech investors in Europe as a spreadsheet?
Yes. The file holds all 291 rows in Excel and CSV, with 880 named decision-makers and 193 firm emails, for $49 one-time. 25 rows are free on this page.
Narrower lists
Related lists
Consumer investors in Europe (65)Edtech investors in Europe (35)Proptech investors in Europe (37)Climate tech investors in Europe (250)Deep tech investors in Europe (299)Hardware investors in Europe (18)Impact investors in Europe (52)Food and beverage investors in Europe (67)Healthtech venture capital firms in the US (709)SaaS investors in Europe (239)AI investors in Europe (230)Healthtech investors in the UK (194)Fintech investors in Europe (140)Energy investors in Europe (103)B2B investors in Europe (102)Biotech investors in Europe (89)Cybersecurity investors in Europe (64)Agritech investors in Europe (63)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to healthtech and digital health and Europe. Guide: how to find investors for a healthtech and digital health startup. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.